Thiamine Injection Shortage
Last Updated: February 22, 2023
Status: Current
Reason for the Shortage
-
- Eugia has thiamine injection available.
- Fresenius Kabi has thiamine injection available.
- Hikma has thiamine injection available.
- Mylan Institutional (Viatris) has thiamine injection available.
- Sagent has thiamine injection available.
Available Products
-
- Thiamine injection, Eugia US, 100 mg/mL, 2 mL vial, 25 count, NDC 55150-0273-25
- Thiamine injection, Fresenius Kabi, 100 mg/mL, 2 mL vial, 25 count, NDC 63323-0013-02
- Thiamine injection, Hikma, 100 mg/mL, 2 mL vial, 25 count, NDC 00641-6228-25
- Thiamine injection, Mylan Institutional (Viatris), 100 mg/mL, 2 mL vial, 25 count, NDC 67457-0196-02
- Thiamine injection, Sagent, 100 mg/mL, 2 mL vial, 25 count, NDC 25021-0500-02
Estimated Resupply Dates
-
- All marketed presentations are available.
Updated
Updated February 22, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. Created January 12, 2022 by Leslie Jensen, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.